tiprankstipranks
Kontafarma China Holdings Ltd (HK:1312)
HKEX:1312
Hong Kong Market

Kontafarma China Holdings Ltd (1312) Stock Price & Analysis

0 Followers

1312 Stock Chart & Stats

Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.03 - HK$0.05
Previous CloseHK$0.03
Volume0.00
Average Volume (3M)391.73K
Market Cap
HK$189.68M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)
Beta0.10
Aug 26, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding5,588,571,777
10 Day Avg. Volume745,200
30 Day Avg. Volume391,733
Standard Deviation0.14
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

1312 FAQ

What was Kontafarma China Holdings Ltd’s price range in the past 12 months?
Kontafarma China Holdings Ltd lowest stock price was HK$0.03 and its highest was HK$0.04 in the past 12 months.
    What is Kontafarma China Holdings Ltd’s market cap?
    Currently, no data Available
    When is Kontafarma China Holdings Ltd’s upcoming earnings report date?
    Kontafarma China Holdings Ltd’s upcoming earnings report date is Aug 26, 2024 which is in 56 days.
      How were Kontafarma China Holdings Ltd’s earnings last quarter?
      Kontafarma China Holdings Ltd released its earnings results on Mar 28, 2024. The company reported -HK$0.012 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.012.
        Is Kontafarma China Holdings Ltd overvalued?
        According to Wall Street analysts Kontafarma China Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Kontafarma China Holdings Ltd pay dividends?
          Kontafarma China Holdings Ltd pays a Notavailable dividend of <HK$0.01 which represents an annual dividend yield of N/A. See more information on Kontafarma China Holdings Ltd dividends here
            What is Kontafarma China Holdings Ltd’s EPS estimate?
            Kontafarma China Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Kontafarma China Holdings Ltd have?
            Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding.
              What happened to Kontafarma China Holdings Ltd’s price movement after its last earnings report?
              Kontafarma China Holdings Ltd reported an EPS of -HK$0.012 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Kontafarma China Holdings Ltd?
                Currently, no hedge funds are holding shares in HK:1312
                ---

                Kontafarma China Holdings Ltd Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                -12.82%
                12-Months-Change

                Fundamentals

                Return on Equity
                -2.67%
                Trailing 12-Months
                Asset Growth
                -18.54%
                Trailing 12-Months
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis